Patent · US Expired

Antiviral composition comprising glycine amide

US7012129B2 · kind B2 · utility

3Cited by

35References

19Claims

0Family size

Assignee

TRIPEP AB · SE

Inventors

Anders Vahlne · Strömstad, SE
Laura Goobar-Larsson · Stockholm, SE

Key dates

Filing date	Apr 1, 2003
Grant date	Mar 14, 2006
Priority date	—
Expiry date	Sep 16, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/0812
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments relate to the discovery that certain tripeptide amides and glycine amide can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said tripeptide amides and/or glycine amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.